A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
Clinical trial NCT04657016 · COMPLETED
Trial details
- NCT number
- NCT04657016
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2023-04-20
- Enrollment
- 579
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.